Invitation to multi-omics 2026 - Brisbane, Australia

Meeting start: 08:00 Sunday 6 December

Meeting end: 20:00 Tuesday 8 December 2026

On behalf of the organising committee, we are delighted to invite you to join us at Multi-Omics 2026, held at the Brisbane Convention & Exhibition Centre, Queensland, Australia, from 6–8 December 2026.

Multi-Omics at the Frontier of Disease Biology

Multi-omics technologies, propelled by rapid innovation in spatial biology, digital pathology, and AI are reshaping our understanding of human disease. From cancer and immunology to infectious disease, the field has evolved from promise to precision, unlocking new layers of insight across tissues, timepoints, and therapeutic contexts.

What to Expect

Over three dynamic days, Multi-Omics 2026 will spotlight the latest breakthroughs in:

  • Spatial Biology Methods and Applications

  • Spatial Medicine

  • Computational Biology

  • AI-powered Omics Analytics

Sessions will span immuno-oncology, infectious disease, and computational immunology, with a strong emphasis on experimental design, cohort architecture, and translational impact.

Why Attend?

This meeting brings together a critical mass of national and international leaders in multi-omics, offering:

  • Cutting-edge science and real-world datasets

  • Platform launches and hands-on technical workshops

  • Engagement with leading technology providers

  • A collaborative space to shape the future of precision medicine

Whether you're decoding spatial signatures, refining analytical pipelines, or driving clinical translation, Multi-Omics 2026 is your launchpad.

We look forward to welcoming you to Brisbane, where discovery meets translation.

ORGANISING COMMITTEE

2024 highlights

Hear from the world leaders in 2026!


2026 SPEAKERS

  • JOE BEECHEM

    Bruker Spatial Biology Chief Scientific Officer.

  • SARAH BEST

    Laboratory Head and fundamental biology lead in the Brain Cancer Research Lab

  • Carlo Bifulco

    Chief Medical Officer & Medical Director
    Providence Genomics & Providence Cancer Institute, USA

  • JENNIFER BOROWSKY

    Anatomical & Molecular Pathologist, Queensland Health, Australia

  • Oliver Braubach

    Director of Research & Development at Bruker Spatial Biology

  • TULLIA BRUNO

    Assistant Professor in the Department of Immunology at the University of Pittsburgh, USA

  • Caroline Cooper

    Anatomical Pathologist, Pathology Queensland, Princess Alexandra Hospital, Australia

  • Jessica Da Gama Duarte

    Laboratory Head, Department of Cancer Medicine, School of Translational Medicine, Monash University, Australia

  • Rong Fan

    Harold Hodgkinson Professor of Biomedical Engineering, Yale University, USA

  • Alistair Forrest

    Head of Systems Biology and genomics Laboratory and Associate Director, Harry Perkins Institute of Medical Research, University of Western Australia. Australia

  • FERNANDO GUIMARAES

    Associate Professor & Group Leader, Frazer Institute, University of Queensland, Australia

  • ANNABELLE GURWITCH

    Best selling author, USA

  • Ruby Huang

    Program Director
    Smart MHI Program, International College, National Taiwan University, Taiwan

  • Helen McGuire

    Associate Professor
    Faculty of Medicine and Health, University of Sydney, Australia

  • Miranda Orr

    Associate Professor
    Washington University in St Louis, USA

  • MAINTHAN PALENDIRA

    Academic Director of Sydney Cytometry Core Facility

    The University of Sydney, NSW, Australia

  • JIWOON PARK

    Postdocoral Researcher at Weill Cornell Medicine & Harvard Medical School, USA.

  • JASMINE PLUMMER

    Founding Director of the Center for Spatial Omics at St Jude Children’s Research Hospital, USA

  • Hoifung Poon

    General Manager, Real-World Evidence, Microsoft Research, USA

  • Niro Ramachandran

    Global Head of Marketing, 10x Genomics

  • Agus Salim

    Associate Professor in Biostatistics, University of Melbourne, Australia

  • Somponnat Sampattavanich

    Assistant Professor
    Department of Pharmacology, Mahidol University, Thailand

  • DENIS SCHAPIRO

    Group Leader in Spatial omics, Heidelberg University Hospital, Germany

  • Christian Schürch

    Professor
    University Hospital Tübingen, Germany

  • Michael Schnall-Levin

    Chief Technology & Strategy Officer, Founding Scientist, 10x Genomics

  • MARTIN SMITH

    Director of the Ramaciotti Centre for Genomics, University of NSW, Australia

  • Mitchell Stark

    Associate Professor and NHMRC Investigator Fellow, Frazer Institute, University of Queensland, Australia

  • MATT TRAU

    Director, Centre for Personalised Nanomedicine
    The University of Queensland

  • Orazio Vittorio

    The University of NSW, Australia

  • PAUL WARING

    Director: Translational Pathology Consulting Services Ltd, Oxford UK

  • JAMES WILMOTT

    Melanoma Institute Australia, The University of Sydney, Australia

  • Joe Yeong

    Director of ImmunoPathology
    Singapore General Hospital, Singapore

STAY CONNECTED

Fill in your details to join the mailing list and keep up to date with the latest Multi-Omics news and information, including speaker announcements, key dates and program information.